Spurring a biotech craze of its own, the UK plots out pub­lic-pri­vate in­vest­ment plan as part of $1B+ in­dus­try in­fu­sion

With in­vest­ment across life sci­ences as fast and fu­ri­ous as ever, the UK gov­ern­ment thinks its own na­tive in­dus­try is be­ing left be­hind. Not con­tent to let the mo­ment pass, the Ex­che­quer is open­ing the pock­et­book as part of a pub­lic-pri­vate plan to in­fuse near­ly $1 bil­lion in­to the fledg­ling in­dus­try.

British Pa­tient Cap­i­tal, a com­mer­cial arm of the UK gov­ern­ment’s British Busi­ness Bank, will plug $276 mil­lion in­to a se­ries of life sci­ences funds with the in­tent to find and in­vest in UK com­pa­nies work­ing on late-stage “break­through” tech­nol­o­gy across the in­dus­try, the firm said Wednes­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER